Why We Win In The Market: We Listen.

Living with neurologic conditions can present various challenges, especially when it comes to mobility issues. Biomedical Music Solutions, Inc. (BMS) has stepped in with a groundbreaking solution in the form of SoundStepsTM software. This patented software is designed to target and increase the volume of activation in the area of the brain that controls walking and balance. This brain first approach to improve efficient muscle activation is a unique and effective approach to assist patients of all ages and stages of neurologic conditions. Partnering strategically with Biodex Medical Systems, BMS has integrated SoundStepsTM with their Gait Trainer Treadmill System. This collaboration resulted in leading research institutes using SoundSteps™-Music Assisted Therapy (MAT) software in multiple independent studies. 100% of these published studies showed faster and greater treatment outcomes in walking and balance when using SoundSteps™. These results have been published in leading science and medical publications such as Frontiers Of Neurology (2020), Journal of Neuroengineering and Rehabilitation (2019) and Parkinson's and Related Disorders (2022).

The success stories shared in these journals highlight the exceptional outcomes achieved through this innovative software. Looking ahead, BMS is set to further revolutionize the industry by disrupting the way we distribute our software. By introducing the SoundSteps™ Mobile software bundle, the company aims to provide round-the-clock access to SoundStepsTM, enabling patients to benefit from its features at home, in their communities, and during clinic visits. This move not only promises increased revenue streams for BMS but also offers new possibilities for enhanced treatment outcomes. BMS's commitment to providing non-invasive, safe, and effective solutions for neurologic patients is unwavering.

With a continued focus on improving mobility and reducing healthcare costs, the company stands out as a beacon of hope for individuals seeking innovative therapies for their conditions. Furthermore, BMS is actively seeking investment opportunities to further advance our software, increase revenue and scale quickly within our US and EU markets. In conclusion, the advancements made by BMS through the development of SoundStepsTM software hold great promise for the future of neurologic patient care. With a steadfast dedication to innovation and a relentless pursuit of excellence, BMS is poised to make a lasting impact on the lives of millions of individuals around the world facing mobility challenges.